肯尼亚三个地区四个诊所分离的淋病奈瑟菌中氟喹诺酮耐药的出现。
Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya.
机构信息
University of Manitoba, Faculty of Medicine, Department of Medical Microbiology and Infectious Diseases, Winnipeg, MB, Canada.
出版信息
Sex Transm Dis. 2012 May;39(5):332-4. doi: 10.1097/OLQ.0b013e318248a85f.
Abstract
We have recently reported high levels of fluoroquinolone resistance in a single region of Kenya. In this article, we report high prevalence of fluoroquinolone resistance (53.2%) in Neisseria gonorrhoeae isolates from 4 clinics in 3 additional regions of Kenya. These findings highlight the need to change first-line treatment in these settings and the need to evaluate empirical management guidelines for treatment of gonococcal infection in Kenya.
摘要
我们最近报道了肯尼亚单一地区氟喹诺酮类药物耐药率很高。在本文中，我们报告了肯尼亚另外三个地区的 4 家诊所分离的淋病奈瑟菌中氟喹诺酮类药物耐药率（53.2%）很高。这些发现强调了需要在这些环境中改变一线治疗方法，并需要评估肯尼亚淋病感染经验性治疗管理指南。
相似文献
1
Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya.肯尼亚三个地区四个诊所分离的淋病奈瑟菌中氟喹诺酮耐药的出现。
Sex Transm Dis. 2012 May;39(5):332-4. doi: 10.1097/OLQ.0b013e318248a85f.
2
gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.肯尼亚淋病奈瑟菌氟喹诺酮耐药株中 gyrA 和 parC 突变。
BMC Microbiol. 2019 Apr 8;19(1):76. doi: 10.1186/s12866-019-1439-1.
3
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
4
Antimicrobial resistance patterns in among male clients of a sexually transmitted infections clinic in Kisumu, Kenya.肯尼亚基苏木一家性传播感染诊所男性患者的抗菌药物耐药模式。
Int J STD AIDS. 2020 Jan;31(1):46-52. doi: 10.1177/0956462419881087.
5
Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004.2004年印度尼西亚巴厘岛耐氟喹诺酮淋病奈瑟菌
Sex Transm Dis. 2006 Oct;33(10):625-9. doi: 10.1097/01.olq.0000216012.83990.bd.
6
7
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.淋病奈瑟菌在男男性行为者和仅与女性发生性行为的男性中的抗微生物药物耐药性：淋球菌分离株监测项目，2005-2010 年。
Ann Intern Med. 2013 Mar 5;158(5 Pt 1):321-8. doi: 10.7326/0003-4819-158-5-201303050-00004.
8
Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance.1988年至2003年美国淋病奈瑟菌的抗菌药物耐药性：氟喹诺酮耐药性的传播
Ann Intern Med. 2007 Jul 17;147(2):81-8. doi: 10.7326/0003-4819-147-2-200707170-00006.
9
Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.淋病奈瑟菌分离株的头孢菌素药敏性——美国，2000-2010 年。
MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.
10
Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.淋病中氟喹诺酮治疗失败。出现对氟喹诺酮耐药性增强的淋病奈瑟菌菌株。
Sex Transm Dis. 1997 May;24(5):247-50. doi: 10.1097/00007435-199705000-00002.
引用本文的文献
1
Antimicrobial susceptibility surveillance and antimicrobial resistance in in Africa from 2001 to 2020: A mini-review.2001年至2020年非洲的抗菌药物敏感性监测与抗菌药物耐药性：一篇综述。
Front Microbiol. 2023 Apr 6;14:1148817. doi: 10.3389/fmicb.2023.1148817. eCollection 2023.
2
Global status of Azithromycin and Erythromycin Resistance Rates in : A Systematic Review and Meta-analysis.全球阿奇霉素和红霉素耐药率：系统评价和荟萃分析。
Yale J Biol Med. 2022 Dec 22;95(4):465-478. eCollection 2022 Dec.
3
Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.多西环素暴露后预防用于预防肯尼亚接受 HIV 暴露前预防的女性中的性传播感染：一项开放标签随机试验的研究方案。
Trials. 2022 Jun 16;23(1):495. doi: 10.1186/s13063-022-06458-8.
4
A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.撒哈拉以南非洲淋病奈瑟菌和生殖支原体的抗生素耐药性系统评价。
J Antimicrob Chemother. 2022 Jul 28;77(8):2074-2093. doi: 10.1093/jac/dkac159.
5
Neisseria gonorrhoeae infection in female sex workers in an STI clinic in Nairobi, Kenya.肯尼亚内罗毕性传播感染诊所中女性性工作者的淋病奈瑟菌感染。
PLoS One. 2022 Feb 25;17(2):e0263531. doi: 10.1371/journal.pone.0263531. eCollection 2022.
6
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015.加纳 2012-2015 年淋病奈瑟菌的抗菌药物耐药性（AMR）及分子特征。
PLoS One. 2019 Oct 10;14(10):e0223598. doi: 10.1371/journal.pone.0223598. eCollection 2019.
7
gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.肯尼亚淋病奈瑟菌氟喹诺酮耐药株中 gyrA 和 parC 突变。
BMC Microbiol. 2019 Apr 8;19(1):76. doi: 10.1186/s12866-019-1439-1.
8
Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women.对尼日利亚男男性行为者和跨性别女性进行淋病奈瑟菌抗菌药物耐药性标志物的分子筛查。
Int J STD AIDS. 2018 Nov;29(13):1273-1281. doi: 10.1177/0956462418780050. Epub 2018 Jul 4.
9
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.多重耐药性淋病：发现新药的研发路线图。
PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.
10
Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.坦桑尼亚西北部感染艾滋病毒风险较高的女性中可治愈性传播感染的流行病学：症状管理的不足
PLoS One. 2014 Jul 15;9(7):e101221. doi: 10.1371/journal.pone.0101221. eCollection 2014.
本文引用的文献
1
Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.2002 年至 2009 年期间，肯尼亚基苏木的一组年轻男性淋病奈瑟菌分离株中出现了喹诺酮类药物耐药和头孢菌素 MIC 攀升现象。
Antimicrob Agents Chemother. 2011 Aug;55(8):3882-8. doi: 10.1128/AAC.00155-11. Epub 2011 May 23.
2
High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal Kenya.肯尼亚沿海地区淋病奈瑟菌对喹诺酮耐药性的高流行率。
Sex Transm Infect. 2011 Apr;87(3):231. doi: 10.1136/sti.2010.048777. Epub 2011 Feb 9.
3
Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.日本的耐头孢曲松淋病奈瑟菌
Emerg Infect Dis. 2011 Jan;17(1):148-9. doi: 10.3201/eid1701.100397.
4
Sexually transmitted diseases treatment guidelines, 2010.性传播疾病治疗指南，2010 年。
MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110.
5
Emergence and spread of drug resistant Neisseria gonorrhoeae.淋病奈瑟菌耐药性的出现和传播。
J Urol. 2010 Sep;184(3):851-8; quiz 1235. doi: 10.1016/j.juro.2010.04.078.
6
Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.通过分子微生物学方法证实的两例头孢曲松治疗咽淋病失败的病例。
J Med Microbiol. 2009 May;58(Pt 5):683-687. doi: 10.1099/jmm.0.007641-0.
7
Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.南非两个城市尿道分泌物男性中耐环丙沙星淋病相对患病率的上升：与HIV血清阳性的关联
Sex Transm Infect. 2008 Oct;84(5):352-5. doi: 10.1136/sti.2007.029611. Epub 2008 Jul 2.
8
What management is there for gonorrhea in the postquinolone era?在后喹诺酮时代，淋病如何治疗？
Sex Transm Dis. 2006 Jan;33(1):8-10. doi: 10.1097/01.olq.0000194599.97426.a3.
9
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from men with urethritis in Kenya.肯尼亚尿道炎男性患者中淋病奈瑟菌分离株的抗菌药物敏感性
Sex Transm Infect. 1998 Aug;74(4):294-5.
10
Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin.阿奇霉素治疗后出现对阿奇霉素和红霉素耐药的淋病奈瑟菌
Int J STD AIDS. 1997 May;8(5):299-302. doi: 10.1258/0956462971920127.
Zotero 插件